Metformin Sandoz

Metformin Hydrochloride, the active ingredient in Metformin Sandoz, is a biguanide presented as an oral tablet for oral administration. It is employed to improve blood glucose control in adults with type 2 diabetes mellitus by decreasing hepatic glucose output and enhancing peripheral insulin sensitivity.

GNH USA supplies Metformin Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier, providing the product to hospitals, pharmacies and clinics worldwide with consistent quality and regulatory compliance. The company supports global distribution through established logistics networks and adheres to stringent quality assurance standards.

Metformin Sandoz is a biguanide oral antidiabetic that lowers blood glucose by acting on hepatic production and peripheral insulin sensitivity.

- Type 2 diabetes mellitus: Improves glycemic control by reducing fasting and post‑prandial glucose levels. - Impaired glucose tolerance (prediabetes): Helps delay progression to overt diabetes when combined with lifestyle measures. - Polycystic ovary syndrome: May improve insulin resistance and restore more regular menstrual cycles.

Metformin Sandoz is generally well tolerated, but patients may experience adverse reactions.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Diarrhea: frequent loose stools, especially at treatment initiation. - Abdominal discomfort: cramping or bloating. - Metallic taste: transient alteration of taste perception. - Loss of appetite: reduced desire to eat. - Vitamin B12 deficiency: gradual decrease with long‑term use.

Serious or Rare Side Effects: - Lactic acidosis: rare but life‑threatening metabolic acidosis. - Severe skin reactions: such as Stevens‑Johnson syndrome. - Hepatic dysfunction: elevated liver enzymes or hepatitis. - Hypoglycemia: uncommon unless combined with other glucose‑lowering agents. - Pancreatitis: very rare inflammation of the pancreas.

Metformin Sandoz requires careful patient assessment and monitoring. - Renal function: evaluate eGFR before initiation and periodically thereafter. - Lactic acidosis risk: avoid in patients with significant hepatic impairment, hypoxia, or severe infection. - Alcohol consumption: limit intake as it may increase lactic acidosis risk. - Pregnancy: use only if potential benefits justify potential risks to the fetus. - Vitamin B12 monitoring: consider periodic assessment during long‑term therapy. - Store at ambient temperature: keep in the original container, protect from moisture and heat.

Metformin Sandoz can interact with several medicines, requiring dose adjustments or monitoring.

Major Interactions (Avoid): - Iodinated contrast agents: may precipitate acute renal failure and increase lactic acidosis risk. - Cimetidine: can raise metformin plasma concentrations. - Alcohol: synergistic effect on lactic acidosis development.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask hypoglycemia symptoms. - Thiazide diuretics: can attenuate glucose‑lowering effect. - ACE inhibitors or ARBs: monitor renal function and potassium levels.